Search results
Author(s):
Nils Perrin
,
Anita W Asgar
Added:
2 years ago
Author(s):
Somsupha Kanjanauthai
,
Kabir Bhasin
,
Luigi Pirelli
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are considered to be of intermediate, high or prohibitive surgical risk.1–5 As a result of favorable TAVR outcomes and substantial improvements in transcatheter heart valve (THV) technologies and implantation techniques, the feasibility of broadening…
View more
BAV: SAVR versus TAVR
Author(s):
Arthur J Lee
,
Imran Baig
,
Katherine B Harrington
,
et al
Added:
1 year ago
Article
Author(s):
Eden C Payabyab
,
Lindsay S Elbaum
,
Navneet Sharma
,
et al
Added:
2 years ago
Author(s):
Hemal Gada
,
Kendra J Grubb
Added:
1 year ago
Dr Hemal Gada (UPMC Heart and Vascular Institute, US) and his team published an informative review article on “Transcatheter Aortic Valve Replacement Optimization Strategies: Cusp Overlap, Commissural Alignment, Sizing, and Positioning”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited byDr Kendra Grubb(Emory Structural Heart and Valve…
View more
Author(s):
Michael N Young
,
Sammy Elmariah
Added:
3 years ago
Severe aortic valve stenosis (AS) is chronic, progressive illness that confers significant morbidity and mortality. Once symptomatic, patients with severe AS will ultimately succumb to the disease if it is not promptly corrected.1 Historically, surgical aortic valve replacement (SAVR) served as the exclusive therapeutic option to correct this mechanical problem.2 However, in 2002, Alain Cribier…
View more
Author(s):
Marko Banovic
Added:
2 years ago
In this short video interview, Dr Marko Banovic (Clinical centre of Serbia, Belgrade, RS) discusses the AVATAR Trial. The trial evaluated aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis.
Presented first at AHA 2021, the trial showed that early AVR was beneficial at preventing adverse events among patients with asymptomatic…
View more
TAVR Optimization
Author(s):
Saima Siddique
,
Resha Khanal
,
Amit N Vora
,
et al
Added:
2 years ago
Article
Valve-in-valve TAVR
Author(s):
Emily Perdoncin
,
Gaetano Paone
,
Isida Byku
Added:
2 years ago
Article
Author(s):
Samir R Kapadia
Added:
1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement.
In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention…
View more